NGM Biopharmaceuticals, Inc. (NGM)
NASDAQ: NGM · IEX Real-Time Price · USD
1.580
-0.040 (-2.47%)
Mar 28, 2024, 1:34 PM EDT - Market open

NGM Biopharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
-142.38-162.67-120.34-102.49-42.8-0.49-14.16
Depreciation & Amortization
4.325.987.96.567.617.226.44
Share-Based Compensation
28.7232.3826.2415.6512.869.867.72
Other Operating Activities
-22.86-20.1412.97-3.22-18.85-24.19-17.41
Operating Cash Flow
-132.2-144.44-73.23-83.5-41.17-7.6-17.41
Capital Expenditures
-1.25-1.86-1.68-1.88-3.49-5.84-6.42
Change in Investments
115.5416.18-69.97-49.1252.2144.573.63
Investing Cash Flow
114.2914.32-71.65-5148.7238.73-2.8
Share Issuance / Repurchase
1.7854.23149.6636.15180.752.40.34
Other Financing Activities
----0.61--2.2-
Financing Cash Flow
1.7854.23149.6635.54180.750.20.34
Net Cash Flow
-16.14-75.884.78-98.96188.331.33-19.87
Free Cash Flow
-133.45-146.3-74.91-85.38-44.66-13.44-23.84
Free Cash Flow Per Share
-1.62-1.83-0.97-1.25-0.89-2.11-4.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).